10-K Filing

HealthLynked Corp CIK: 1680139 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001213900-21-019166`
Period End Date	20201231
Filing Date	20210331
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	hlyk-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 82 Income Statement 64 Cash Flow Statement 112 Stockholders Equity 34

Balance Sheet 82 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$162.18K	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$110.44K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of December 31, 2020 and 2019, respectively	`AccountsReceivableNetCurrent`	$83.25K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $13,972 and $13,972 as of December 31, 2020 and 2019, respectively	`AccountsReceivableNetCurrent`	$87.15K	USD	Point-in-time
Inventory	`InventoryNet`	$70.46K	USD	Point-in-time
Inventory	`InventoryNet`	$95.20K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$138.53K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$59.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	`AllowanceForDoubtfulAccountsReceivableCurrent`	$13.97K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$402.68K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$403.54K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $177,457 and $749,316 as of December 31, 2020 and 2019, respectively	`PropertyPlantAndEquipmentNet`	$513.79K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation of $177,457 and $749,316 as of December 31, 2020 and 2019, respectively	`PropertyPlantAndEquipmentNet`	$437.29K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$749.32K	USD	Point-in-time
Property, plant and equipment, net of accumulated depreciation (in Dollars)	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$177.46K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $151,776 and $5,908 as of December 31, 2020 and 2019, respectively	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$5.60M	USD	Point-in-time
intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$151.78K	USD	Point-in-time
Intangible assets, net of accumulated amortization of $151,776 and $5,908 as of December 31, 2020 and 2019, respectively	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$1.27M	USD	Point-in-time
intangible assets, net of accumulated amortization (in Dollars)	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$5.91K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	-	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount (in Dollars)	`DebtInstrumentUnamortizedDiscountCurrent`	$777.67K	USD	Point-in-time
Goodwill	`Goodwill`	$71.87K	USD	Point-in-time
Goodwill	`Goodwill`	$1.15M	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$293.12K	USD	Point-in-time
ROU lease assets and deposits	`LeaseAssetsNonCurrent`	$435.86K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Total Assets	`Assets`	$8.03M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Total Assets	`Assets`	$2.55M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.97M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	109.89M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$1.89M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.97M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	109.89M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$836.47K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	$89.42K	USD	Point-in-time
Contract liabilities	`ContractWithCustomerLiabilityCurrent`	-	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$150.25K	USD	Point-in-time
Lease liability, current portion	`OperatingLeaseLiabilityCurrent`	$201.52K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$493.46K	USD	Point-in-time
Due to related party, current portion	`DueToOtherRelatedPartiesClassifiedCurrent`	$300.60K	USD	Point-in-time
Notes payable to related party, current portion	`NotesPayableRelatedPartiesClassifiedCurrent`	$743.96K	USD	Point-in-time
Notes payable to related party, current portion	`NotesPayableRelatedPartiesClassifiedCurrent`	-	USD	Point-in-time
Common stock issuable (in Dollars per share)	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Government and vendor notes payable, current portion	`OtherNotesPayable`	-	USD	Point-in-time
Common stock issuable (in Dollars per share)	`CommonStockIssuableIssuePrice`	$0.00	USD	Point-in-time
Government and vendor notes payable, current portion	`OtherNotesPayable`	$411.43K	USD	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $-0- and $777,668 as of December 31, 2020 and 2019, respectively	`ConvertibleDebtCurrent`	$1.34M	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	2.15M	shares	Point-in-time
Convertible notes payable, net of original issue discount and debt discount of $-0- and $777,668 as of December 31, 2020 and 2019, respectively	`ConvertibleDebtCurrent`	$1.54M	USD	Point-in-time
Common stock issuable, shares	`CommonStockIssuableShares`	1.05M	shares	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$100.00K	USD	Point-in-time
Contingent acquisition consideration, current portion	`BusinessCombinationContingentConsiderationLiabilityCurrent`	$701.96K	USD	Point-in-time
Derivative financial instruments	`DerivativeInstrumentsAndHedgesLiabilities`	-	USD	Point-in-time
Derivative financial instruments	`DerivativeInstrumentsAndHedgesLiabilities`	$991.29K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.91M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$4.88M	USD	Point-in-time
Government and vendor notes payable, long term portion	`LongTermNotesPayable`	-	USD	Point-in-time
Government and vendor notes payable, long term portion	`LongTermNotesPayable`	$722.51K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$400.00K	USD	Point-in-time
Contingent acquisition consideration, long term portion	`CapitalLeaseObligationsNoncurrent`	$798.48K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$273.79K	USD	Point-in-time
Lease liability, long term portion	`OperatingLeaseLiabilityNoncurrent`	$80.51K	USD	Point-in-time
Total Liabilities	`Liabilities`	$6.68M	USD	Point-in-time
Total Liabilities	`Liabilities`	$5.39M	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 187,967,881 and 109,894,490 shares issued and outstanding as of December 31, 2020 and 2019, respectively Series B convertible preferred stock, par value $0.001 per share, 20,000,000	`CommonStockValue`	$18.80K	USD	Point-in-time
Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 187,967,881 and 109,894,490 shares issued and outstanding as of December 31, 2020 and 2019, respectively Series B convertible preferred stock, par value $0.001 per share, 20,000,000	`CommonStockValue`	$10.99K	USD	Point-in-time
Series B convertible preferred stock, par value $0.001 per share, 20,000,000 shares authorized, 2,750,000 and -0- shares issued and outstanding as of December 31, 2020 and 2019, respectively	`PreferredStockValue`	$2.75K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 2,150,020 and 1,047,904 shares as of December 31, 2020 and 2019, respectively	`CommonStockIssuableValue`	$159.54K	USD	Point-in-time
Common stock issuable, $0.0001 par value; 2,150,020 and 1,047,904 shares as of December 31, 2020 and 2019, respectively	`CommonStockIssuableValue`	$262.27K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$13.02M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$22.85M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-21.78M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.03M	USD	Point-in-time
Total Shareholders Equity (Deficit)	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Total Shareholders Equity (Deficit)	`StockholdersEquity`	$1.35M	USD	Point-in-time
Total Shareholders Equity (Deficit)	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Total Liabilities and Shareholders Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$8.03M	USD	Point-in-time
Total Liabilities and Shareholders Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$2.55M	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$4.74M	USD	Annual
Patient service revenue, net	`RevenueFromContractWithCustomerIncludingAssessedTax`	$4.02M	USD	Annual
Medicare shared savings revenue	`MedicareSharedSavingRevenues`	-	USD	Annual
Medicare shared savings revenue	`MedicareSharedSavingRevenues`	$767.74K	USD	Annual
Consulting revenue	`ConsultingRevenue`	-	USD	Annual
Consulting revenue	`ConsultingRevenue`	$432.98K	USD	Annual
Product revenue	`ProductRevenue`	$188.59K	USD	Annual
Product revenue	`ProductRevenue`	-	USD	Annual
Total revenue	`Revenues`	$4.02M	USD	Annual
Total revenue	`Revenues`	$6.13M	USD	Annual
Practice salaries and benefits	`LaborAndRelatedExpense`	$2.58M	USD	Annual
Practice salaries and benefits	`LaborAndRelatedExpense`	$2.39M	USD	Annual
Other practice operating expenses	`OperatingCostsAndExpenses`	$1.85M	USD	Annual
Other practice operating expenses	`OperatingCostsAndExpenses`	$2.15M	USD	Annual
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	-	USD	Annual
Medicare shared savings expenses	`OtherCostAndExpenseOperating`	$1.02M	USD	Annual
Cost of product revenue	`CostOfRevenues`	$146.46K	USD	Annual
Cost of product revenue	`CostOfRevenues`	-	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$2.92M	USD	Annual
Selling, general and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$3.06M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$247.37K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$73.39K	USD	Annual
Total Operating Expenses and Costs	`OperatingExpenses`	$7.23M	USD	Annual
Total Operating Expenses and Costs	`OperatingExpenses`	$9.20M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-3.21M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-3.07M	USD	Annual
Loss on sales of marketable securities	`HeldToMaturitySecuritiesTransferredToTradingSecuritiesUnrealizedGainLoss`	$-282.11K	USD	Annual
Loss on sales of marketable securities	`HeldToMaturitySecuritiesTransferredToTradingSecuritiesUnrealizedGainLoss`	-	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.23M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.35M	USD	Annual
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-381.83K	USD	Annual
Change in fair value of debt	`GainsLossesOnRestructuringOfDebt`	$-121.51K	USD	Annual
Financing cost	`AmortizationOfFinancingCosts`	$135.53K	USD	Annual
Financing cost	`AmortizationOfFinancingCosts`	-	USD	Annual
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-530.93K	USD	Annual
Amortization of original issue and debt discounts on notes payable and convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-1.26M	USD	Annual
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$739.49K	USD	Annual
Change in fair value of derivative financial instruments	`GainLossOnDerivativeInstrumentsNetPretax`	$671.82K	USD	Annual
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	-	USD	Annual
Change in fair value of contingent acquisition consideration	`GainLossOnChangeInFairValueOfContingentAcquisitionConsideration`	$75.95K	USD	Annual
Loss on settlement of litigation and other dispute	`LitigationSettlementExpense`	-	USD	Annual
Loss on settlement of litigation and other dispute	`LitigationSettlementExpense`	$706.86K	USD	Annual
Interest expense	`InterestExpenseOther`	$249.76K	USD	Annual
Interest expense	`InterestExpenseOther`	$244.09K	USD	Annual
Total other expenses	`NonoperatingIncomeExpense`	$-2.68M	USD	Annual
Total other expenses	`NonoperatingIncomeExpense`	$-2.32M	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.76M	USD	Annual
Net loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.53M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Net loss	`NetIncomeLoss`	$-5.76M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.53M	USD	Annual
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`OtherPreferredStockDividendsAndAdjustments`	-	USD	Annual
Deemed dividend - amortization of beneficial conversion feature and down round adjustment to warrants	`OtherPreferredStockDividendsAndAdjustments`	$446.04K	USD	Annual
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.20M	USD	Annual
Net loss to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.53M	USD	Annual
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.06	USD	Annual
Basic (in Dollars per share)	`EarningsPerShareBasic`	$-0.04	USD	Annual
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.04	USD	Annual
Fully diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-0.06	USD	Annual
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	99.06M	shares	Annual
Basic (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	142.82M	shares	Annual
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	142.82M	shares	Annual
Fully diluted (in Shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.06M	shares	Annual

Cash Flow Statement 112 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.76M	USD	Annual
Net loss	`NetIncomeLoss`	$-5.53M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$247.37K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$73.39K	USD	Annual
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$564.67K	USD	Annual
Stock based compensation, including amortization of prepaid fees	`EmployeeBenefitsAndShareBasedCompensation`	$519.93K	USD	Annual
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremiums`	$530.93K	USD	Annual
Amortization of original issue discount and debt discount on convertible notes	`InvestmentIncomeNetAmortizationOfDiscountAndPremiums`	$1.26M	USD	Annual
Loss on sales of marketable securities	`MarketableSecuritiesUnrealizedGainLosses`	-	USD	Annual
Loss on sales of marketable securities	`MarketableSecuritiesUnrealizedGainLosses`	$282.11K	USD	Annual
Financing cost	`AmortizationOfFinancingCosts`	$135.53K	USD	Annual
Financing cost	`AmortizationOfFinancingCosts`	-	USD	Annual
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstruments`	$739.49K	USD	Annual
Change in fair value of derivative financial instruments	`ChangeInFairValueOfDerivativeFinancialInstruments`	$671.82K	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.23M	USD	Annual
Loss on extinguishment of debt	`GainsLossesOnExtinguishmentOfDebt`	$-1.35M	USD	Annual
Change in fair value of debt	`NoncashExpense`	$121.51K	USD	Annual
Change in fair value of debt	`NoncashExpense`	$381.83K	USD	Annual
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	-	USD	Annual
Change in fair value of contingent acquisition consideration	`GainLossesOnChangeInFairValueOfContingentAcquisitionConsideration`	$75.95K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-86.30K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-31.63K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-1.65K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$24.74K	USD	Annual
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-73.12K	USD	Annual
Prepaid expenses and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$96.70K	USD	Annual
ROU lease assets	`AmortizationOfLeaseAssets`	$282.37K	USD	Annual
ROU lease assets	`AmortizationOfLeaseAssets`	$222.78K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$492.21K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$983.90K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiability`	$221.01K	USD	Annual
Lease liability	`IncreaseDecreaseInLeaseLiability`	$278.02K	USD	Annual
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$63.77K	USD	Annual
Due to related party, current portion	`IncreaseDecreaseInDueToRelatedPartiesCurrent`	$46.37K	USD	Annual
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	$-67.61K	USD	Annual
Contract liabilities	`IncreaseDecreaseInDeferredRevenue`	-	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.12M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.36M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleOfMarketableSecurity`	-	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleOfMarketableSecurity`	$2.78M	USD	Annual
Acquisition, net of cash acquired	`PaymentToAcquireBusinessesNetOfCashAcquired`	$465.00K	USD	Annual
Acquisition, net of cash acquired	`PaymentToAcquireBusinessesNetOfCashAcquired`	$810.16K	USD	Annual
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$137.39K	USD	Annual
Payment of contingent acquisition consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	-	USD	Annual
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$25.00K	USD	Annual
Acquisition of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.06K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-475.06K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.81M	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.19M	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.66M	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$275.00	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$2.17M	USD	Annual
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$827.50K	USD	Annual
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$1.02M	USD	Annual
Repayment of convertible notes	`RepaymentsOfConvertibleDebt`	$1.88M	USD	Annual
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Proceeds from related party loans	`ProceedsFromRelatedPartyDebt`	$149.00K	USD	Annual
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	-	USD	Annual
Repayment of related party loans	`RepaymentsOfRelatedPartyDebt`	$967.76K	USD	Annual
Proceeds from government loans	`ProceedsFromIssuanceOfOtherLongTermDebt`	$1.07M	USD	Annual
Proceeds from government loans	`ProceedsFromIssuanceOfOtherLongTermDebt`	-	USD	Annual
Repayment of notes payable	`RepaymentsOfNotesPayable`	$27.89K	USD	Annual
Repayment of notes payable	`RepaymentsOfNotesPayable`	-	USD	Annual
Repurchase and retirement of treasury stock	`PaymentsForRepurchaseOfCommonStock`	$1.20K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.81M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$356.80K	USD	Annual
Net increase (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$51.74K	USD	Annual
Net increase (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-25.34K	USD	Annual
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$162.18K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$110.44K	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$135.78K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$162.18K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$110.44K	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$135.78K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$38.13K	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	$203.40K	USD	Annual
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	Annual
Cash paid during the period for income tax	`IncomeTaxesPaid`	-	USD	Annual
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$211.50K	USD	Annual
Initial derivative liability and fair value of beneficial conversion feature and original issue discount allocated to proceeds of variable convertible notes payable	`FairValueOfWarrantsBeneficialConversionFeatureAndOriginalIssueDiscount`	$1.87M	USD	Annual
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$66.16K	USD	Annual
Common stock issuable issued during period	`CommonStockToBeIssuedNowIssued`	$35.00	USD	Annual
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	$54.26K	USD	Annual
Fair value of warrants issued for professional service	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$1.67M	USD	Annual
Conversion of convertible note payable to common shares	`ConversionOfConvertibleNotesPayableToCommonStock`	$1.22M	USD	Annual
Fair value of common shares issued with convertible notes payable	`Fairvalueofcommonsharesissuedwithconvertiblenotespayable`	$28.32K	USD	Annual
Fair value of common shares issued with convertible notes payable	`Fairvalueofcommonsharesissuedwithconvertiblenotespayable`	-	USD	Annual
Cashless exercise of options and warrants	`Cashlessexerciseofwarrants`	$230.00	USD	Annual
Cashless exercise of options and warrants	`Cashlessexerciseofwarrants`	-	USD	Annual
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	$560.05K	USD	Annual
Adoption of lease obligation and ROU asset	`AdoptionOfLeaseObligationAndROUAsset`	$365.56K	USD	Annual
Fair value of shares issued as acquisition consideration	`FairValueOfSharesIssuedAsContingentAcquisitionConsideration`	$1.00M	USD	Annual
Fair value of shares issued as acquisition consideration	`FairValueOfSharesIssuedAsContingentAcquisitionConsideration`	$2.91M	USD	Annual
Fair value of contingent acquisition consideration issued	`FairValueOfContingentAcquisitionConsiderationIssued`	$2.00M	USD	Annual
Fair value of contingent acquisition consideration issued	`FairValueOfContingentAcquisitionConsiderationIssued`	$500.00K	USD	Annual
Fair value of warrants issued and modifications of beneficial conversion feature to extend convertible notes payable	`FairValueOfWarrantsIssuedAndModificationsOfBeneficialConversionFeature`	-	USD	Annual
Fair value of warrants issued and modifications of beneficial conversion feature to extend convertible notes payable	`FairValueOfWarrantsIssuedAndModificationsOfBeneficialConversionFeature`	$703.27K	USD	Annual
Fair value of warrants issued to extend related party notes payable	`FairValueOfWarrantsIssuedToExtendRelatedPartyNotesPayable`	-	USD	Annual
Fair value of warrants issued to extend related party notes payable	`FairValueOfWarrantsIssuedToExtendRelatedPartyNotesPayable`	$274.80K	USD	Annual
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$328.00K	USD	Annual
Derivative liabilities written off with repayment of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithRepaymentOfConvertibleNotesPayable`	$608.39K	USD	Annual
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	-	USD	Annual
Derivative liabilities written off with conversion of convertible notes payable	`DerivativeLiabilitiesWrittenOffWithConversionOfConvertibleNotesPayable`	$135.30K	USD	Annual
Reduction in contingent acquisition consideration	`ReductionInContingentAcquisitionConsideration`	-	USD	Annual
Reduction in contingent acquisition consideration	`ReductionInContingentAcquisitionConsideration`	$200.33K	USD	Annual
Fair value of marketable securities received as consideration for sale of common and preferred shares	`FairValueOfMarketableSecuritiesReceivedAsConsiderationForSaleOfCommonAndPreferredSh`	-	USD	Annual
Fair value of marketable securities received as consideration for sale of common and preferred shares	`FairValueOfMarketableSecuritiesReceivedAsConsiderationForSaleOfCommonAndPreferredSh`	$3.07M	USD	Annual
Fair value of warrants allocated to proceeds of fixed convertible notes payable	`FairValueOfWarrantsAllocatedToProceedsOfFixedConvertibleNotesPayable`	-	USD	Annual
Fair value of warrants allocated to proceeds of fixed convertible notes payable	`FairValueOfWarrantsAllocatedToProceedsOfFixedConvertibleNotesPayable`	$225.32K	USD	Annual
Gain on extinguishment of related party debt allocated to additional paid in capital	`GainOnExtinguishmentOfRelatedPartyDebtsAllocatedToAdditionalPaidInCapital`	$283.86K	USD	Annual
Gain on extinguishment of related party debt allocated to additional paid in capital	`GainOnExtinguishmentOfRelatedPartyDebtsAllocatedToAdditionalPaidInCapital`	-	USD	Annual

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.93M	USD	Point-in-time
Balance	`StockholdersEquity`	$1.35M	USD	Point-in-time
Balance	`StockholdersEquity`	$-2.84M	USD	Point-in-time
Acquisition of Hughes Center for Functional Medicine	`StockIssuedDuringPeriodValueAcquisitions`	$1.00M	USD	Annual
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$1.50M	USD	Annual
Sales of common stock	`StockIssuedDuringPeriodValueNewIssues`	$1.00M	USD	Annual
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$154.65K	USD	Annual
Fair value of warrants allocated to proceeds of common stock	`StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants`	$186.28K	USD	Annual
Sale of common and preferred stock in exchange for marketable securities	`SaleOfCommonAndPreferredStockInExchangeForMarketableSecurities`	$3.07M	USD	Annual
Shares issued with convertible notes payable	`Sharesissuedwithconvertiblenotespayable`	$28.32K	USD	Annual
Fair value of warrants allocated to proceeds of convertible notes payable	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$225.32K	USD	Annual
Fair value of warrants issued and modifications of beneficial conversion feature to extend convertible notes payable	`StockIssuedDuringPeriodValueConversionOfUnits`	$1.05M	USD	Annual
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.67M	USD	Annual
Conversion of convertible notes payable to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.22M	USD	Annual
Gain on extinguishment of related party debt allocated to additional paid in capital	`GainOnExtinguishmentOfRelatedPartyDebtAllocatedToAdditionalPaidInCapital`	$283.86K	USD	Annual
Acquisition of Cura Health Management LLC	`AcquisitionOfCuraHealthManagementLLC`	$201.68K	USD	Annual
Acquisition of MedOffice Direct LLC	`AcquisitionOfMedOfficeDirectLLC`	$2.70M	USD	Annual
Contingent acquisition consideration issued	`ContingentAcquisitionConsiderationIssued`	$292.78K	USD	Annual
Fair value of warrants issued for professional services	`AdjustmentsToAdditionalPaindInCapitalCommonStock`	$54.26K	USD	Annual
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$175.32K	USD	Annual
Consultant and director fees payable with common shares and warrants	`ConsultantFeesPayableWithCommonSharesAndWarrants`	$313.87K	USD	Annual
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$213.53K	USD	Annual
Shares and options issued pursuant to employee equity incentive plan	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$231.60K	USD	Annual
Exercise of stock options	`ExerciseOfStockOptionsValue`	-	USD	Annual
Exercise of stock warrants	`Exerciseofwarrants`	$275.00	USD	Annual
Exercise of stock warrants	`Exerciseofwarrants`	-	USD	Annual
Exercise of stock warrants (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	-	shares	Annual
Exercise of stock warrants (in Shares)	`StockIssuedDuringPeriodSharesStockOptionsExercised`	154,166.00	shares	Annual
Repurchase of treasury stock	`RepurchaseOfTreasuryStock`	$-1.20K	USD	Annual
Net loss	`ProfitLoss`	$-5.76M	USD	Annual
Net loss	`ProfitLoss`	$-5.53M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.